Search results for: 'New tech Market presence segments DDOS mitigation'

20 Mar 2019  |  North America  |  Market Research

Growth Opportunities in the North American Clinical Laboratory Services Market, Forecast to 2022

Laboratories Seek Alternate Revenue Streams to Combat Reimbursement Pressure

Infographics

×

Clinical laboratory services represent one of the highest healthcare expenditures in North America, yet the United States and Canada represent different scenarios in the way clinical services are rendered. The market for clinical lab services in Canada was an estimated $10.33 billion in 2017 whereas in the United States it was an estimated $78.33 b...

11 Sep 2018  |  Europe  |  Market Research

Growth Opportunities in the Nordic Region Facility Management Market

Service Innovation and Contract Integration to Drive Growth and Industry Transformation

Infographics

×

Key Issues Addressed

The facility management (FM) market in the Nordic region is one of the most advanced in the world, but it's also one of the most mature and revenue growth is becoming hard to find. Companies need to innovate around technology, new business models, emerging value propositions, and creative new service offerings to find ways to deliver profitable an...

Frost and Sullivan expects 2023 to be the year of resilience. Businesses will face a range of challenges, including a global economic slowdown, supply chain bottlenecks, and geopolitical shocks. Organizations of all sizes and types will be compelled to find new areas for growth, despite an abrupt downturn in consumer demand. This study identifi...

25 Jul 2022  |  Global  |  Market Research

US Healthcare Supply Chain Growth Opportunities

New Tracking Software for Inventory Cycle and Risk Management Eases Demand Pressure in Post-Pandemic Environment

Infographics

×

Healthcare supply chain software monitors procurement and distribution data to track inventory and supply within healthcare systems. The healthcare supply chain software vendors in this study offer a range of solutions to providers, such as tracking workflow, monitoring suppliers for risk, and using compiled data to predict future availability of s...

14 Mar 2017  |  Asia Pacific  |  Megatrends

Future of ASEAN, Forecast to 2025

Potential Contribution of the Integration of 10 SEA Nations to Regional Growth and New Opportunities across Sectors

Infographics

×

ASEAN’s GDP is forecast to increase from $2.4 Trillion in 2015 to $5.2 Trillion in 2025, largely due to the ongoing implementation of the AEC. This study examines the potential contributions of this integration to regional growth by analysing the impact of various Mega Trends and expanding on the predictions for each sector. It also analyses the ne...

Post-pandemic, 2022 has triggered a unique set of challenges that are already causing major disruptions to business. As countries are slowly recovering from the pandemic, year 2022 has already caused severe damage to business confidence, ranging from economic slowdown, to the Russo-Ukrainian War, to supply chain disruptions, to talent shortages, to...

Curbsides are becoming the next battleground for cities, primarily because the use of curbside spaces is no longer restricted to parking. They now include eHailing vehicles dropping and picking up customers, delivery vehicles dropping off and picking up packages. Microtransit assets, such as bikes and scooters now occupy the sidewalk. Cities do not...

This study features emerging Trend Opportunity Profiles that share novel business outlooks in the form of models, which offer convenience to customers and profit to owners through advanced technology usage, increased digital presence, and strategic collaborations. With a shift to convenience and ease of access as the focal point for consumers, c...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...